Metropolitan Life Insurance CO Satsuma Pharmaceuticals, Inc. Transaction History

Metropolitan Life Insurance CO

  • $253 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$3.85 - $28.47 $12,135 - $89,737
-3,152 Closed
0 $0
Q2 2020

Jun 26, 2023
BUY
$16.01 - $34.69 $50,463 - $109,342
3,152 New
3,152 $90,000
Q2 2020

Mar 30, 2023
BUY
$16.01 - $34.69 $50,463 - $109,342
3,152 New
3,152 $90,000
Q2 2020

Aug 14, 2020
BUY
$16.01 - $34.69 $50,463 - $109,342
3,152 New
3,152 $91,000

About Satsuma Pharmaceuticals, Inc.

STSA Quotes by TradingView
  • Ticker STSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,587,500
  • Description
  • Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can ...
More about STSA
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email